a memory T-cell booster to enhance the efficacy and long-term immunity of SARS-CoV-2 vaccines
- Funded by Innosuisse
- Total publications:0 publications
Grant number: 47189.1 IP-LS
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$175,969.6Funder
InnosuissePrincipal Investigator
Pedro RomeroResearch Location
SwitzerlandLead Research Institution
University of Lausanne - LAResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
This project aims to develop an orally administered memory T-cell booster for SARS-CoV-2 vaccines to provide faster & longer protection with less vaccine material. This solution could alleviate manufacturing bottlenecks ultimately accelerating the pace of immunization at the global scale.